ASX:OSL OncoSil Medical (OSL) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About OncoSil Medical Stock (ASX:OSL) 30 days 90 days 365 days Advanced Chart Get OncoSil Medical alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume2.17 million shsAverage VolumeN/AMarket CapitalizationA$32.25 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia. Read More Receive OSL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OncoSil Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address OSL Stock News HeadlinesASX:OSL Financials | Oncosil Medical Ltd - Investing.comJuly 8, 2025 | investing.comOncoSil wraps up recruitment for key pancreatic cancer trialJuly 4, 2025 | msn.comAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. While the crowd buys Bitcoin outright, trader Larry Benedict is using a method called “Bitcoin Skimming” to target 6x, 9x, even 22x bigger profits. He reveals how it works in a free video. | Brownstone Research (Ad)OncoSil Medical’s Device Outperforms SBRT in Pancreatic Cancer TreatmentMay 6, 2025 | tipranks.comOncoSil Medical Advances in German Market with New Study TenderApril 30, 2025 | tipranks.comOncoSil Medical Appoints Lel Smits to Enhance Strategic GrowthJanuary 14, 2025 | tipranks.comDr Boreham’s Crucible: Will ditching its baggage help this pancreatic cancer-targeting outfit soar?December 4, 2024 | msn.comOncoSil Medical Expands Global Reach and Financial StrengthNovember 20, 2024 | markets.businessinsider.comSee More Headlines OSL Stock Analysis - Frequently Asked Questions What other stocks do shareholders of OncoSil Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that OncoSil Medical investors own include Invictus Energy (IVZ), Citizens (CIA), Red Mountain Mining (RMX), National Australia Bank (NAB), Rivian Automotive (RIVN), Blackmores (BKL) and Twitter (TWTR). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolASX:OSL CIKN/A Webwww.oncosil.com.au Phone61 2 9223 3344FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)A($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-A$11.91 million Net Margins-2,395.37% Pretax MarginN/A Return on Equity-280.65% Return on Assets-82.34% Debt Debt-to-Equity Ratio1.49 Current Ratio3.26 Quick Ratio6.89 Sales & Book Value Annual SalesA$1.57 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow10.91 Book ValueA$0.00 per share Price / BookN/AMiscellaneous Outstanding Shares3,780,000,000Free FloatN/AMarket CapA$32.25 million OptionableNot Optionable Beta0.91 10 Stocks Set to Soar in Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (ASX:OSL) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OncoSil Medical Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share OncoSil Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
